Related Experiment Video
Updated: Jul 12, 2026

Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress
Published on: August 31, 2015
Benzo[b]thiophenesulphonamide 1,1-dioxide derivatives inhibit tNOX activity in a redox state-dependent manner
1Department of Health Sciences, Universidad Pública de Navarra, Avda. Barañain, 31008 Pamplona, Spain.
Abstract:
Benzo[b]thiophenesulphonamide 1,1-dioxide (BTS) derivatives are strong cytotoxic agents that induce reactive oxygen species (ROS) overproduction and apoptosis in tumour cells. Although the precise origin of BTS-induced ROS is not known, a clear correlation between their cytotoxic effect and ability to inhibit a tumour-associated NADH oxidase (tNOX) activity of the plasma membrane has been described. To analyse the putative implication of tNOX in BTS-induced ROS generation, in this work we have synthesised and tested a new BTS derivative, the 6-[N-(2-phenylethyl)]benzo[b]thiophenesulphonamide 1,1-dioxide. According to its high lipophilicity, this compound showed a strong cytotoxic activity against a panel of six human tumour cell lines, including two human leukaemia (K-562 and CCRF-CEM) and four human solid tumours (HT-29, HTB54, HeLa and MEL-AC). We also tested the ability of this compound to inhibit the tNOX activity and we found an absolute dependence of this inhibition on the redox state of the tNOX: while under reducing conditions, that is, 100 mM GSH, the drug inhibits strongly the NOX activity with an EC(50) of about 0.1 nM, under oxidising conditions, there is no effect of the drug or just a slight stimulation of activity.
Insights
New benzo[b]thiophenesulphonamide 1,1-dioxide (BTS) derivatives show potent anticancer activity by inhibiting tumour-associated NADH oxidase (tNOX). This inhibition is redox-dependent, highlighting a novel therapeutic strategy for cancer treatment.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Benzo[b]thiophenesulphonamide 1,1-dioxide (BTS) derivatives are cytotoxic agents inducing reactive oxygen species (ROS) and apoptosis in tumor cells.
- A correlation exists between BTS cytotoxicity and inhibition of plasma membrane tumour-associated NADH oxidase (tNOX) activity.
- The precise origin of BTS-induced ROS remains unclear.
Purpose of the Study:
- To synthesize and evaluate a novel BTS derivative for its cytotoxic and tNOX inhibitory activities.
- To investigate the role of tNOX in BTS-induced ROS generation.
- To analyze the influence of redox state on tNOX inhibition by the new BTS derivative.
Main Methods:
- Synthesis of 6-[N-(2-phenylethyl)]benzo[b]thiophenesulphonamide 1,1-dioxide.
- Assessment of cytotoxic activity against six human tumor cell lines (leukemia and solid tumors).
- Evaluation of tNOX inhibitory activity under reducing and oxidizing conditions.
Main Results:
- The novel BTS derivative exhibited strong cytotoxic activity across various human tumor cell lines.
- The compound demonstrated potent inhibition of tNOX activity with an EC(50) of approximately 0.1 nM under reducing conditions (100 mM GSH).
- tNOX inhibition was highly dependent on the redox state, showing no effect or slight stimulation under oxidizing conditions.
Conclusions:
- The synthesized BTS derivative is a potent cytotoxic agent against human tumors.
- The compound's efficacy is linked to the redox-dependent inhibition of tNOX.
- This finding supports the targeting of tNOX as a potential anticancer strategy.
Related Concept Videos
Reactions at the Benzylic Position: Oxidation and Reduction
Electrophilic Aromatic Substitution: Sulfonation of Benzene
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
Antihypertensive Drugs: Thiazide-Class Diuretics
Phase I Reactions: Reductive Reactions
Antiprotozoal Agents

